Código QR (código de barras bidimensional)

Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency

Abstract Background Renal insufficiency is one of the most common complications in the treatment of multiple myeloma (MM). The administration of isatuximab showed improved patient outcome regarding the occurrence of renal insufficiency. Building on the results of the ICARIA-MM study, the aim of this...

ver descrição completa

Na minha lista:
Principais autores: F. Jakobs, P. Ahmadi, V. Osterkamp, J. Jeck, U. Holtick, C. Scheid, Florian Kron
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-03-01
coleção:Cost Effectiveness and Resource Allocation
Assuntos:
Multiple myeloma
Renal insufficiency
Cost savings
Isatuximab
Hospital management
Acesso em linha:https://doi.org/10.1186/s12962-024-00600-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados